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ORIGINAL ARTICLEFibroblast-Derived MMP-14 Regulates
Collagen Homeostasis in Adult Skin
Paola Zigrino1, Ju¨rgen Brinckmann2,3, Anja Niehoff4, Yinhui Lu5, Nives Giebeler1,
Beate Eckes1, Karl E. Kadler5 and Cornelia Mauch1Proteolytic activities in the extracellular matrix by the matrix metalloproteinase (MMP)-14 have been implicated
in the remodeling of collagenous proteins during development. To analyze the function of fibroblast-derived
MMP-14 in adult skin homeostasis, we generated mice with inducible deletion of MMP-14 in the dermal
fibroblast (MMP-14Sfe/e). These mice are smaller and display a fibrosis-like phenotype in the skin. The skin of
these mice showed increased stiffness and tensile strength but no altered collagen cross-links. In vivo, we
measured a significantly increased amount of collagen type I accumulated in the skin of MMP-14Sfe/e mice
without an increase in collagen fibril diameters. However, bleomycin-induced fibrosis in skin proceeded in
a comparable manner in MMP-14Sfþ/þ and MMP-14Sfe/e mice, but resolution over time was impaired in
MMP-14Sfe/emice. Increased accumulation of collagen type I was detected in MMP-14Sfe/e fibroblasts in culture
without significant enhancement of collagen de novo synthesis. This points to a degradative but not synthetic
phenotype. In support of this, MMP-14Sfe/e fibroblasts lost their ability to process fibrillar collagen type I and to
activate proMMP-2. Taken together, these data indicate that MMP-14 expression in fibroblasts plays a crucial
role in collagen remodeling in adult skin and largely contributes to dermal homeostasis underlying its path-
ogenic role in fibrotic skin disease.
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Matrix metalloproteinases (MMPs) play a crucial role in the
maintenance of the normal balance between extracellular
matrix (ECM) synthesis and degradation in tissues. This class
of proteolytic enzymes are Zn-dependent endopeptidases,
subdivided according to their structural characteristics in
secreted and membrane-bound MMPs (MT-MMPs). They
display a certain degree of substrate specificity but can often
compensate for each other for the processing of some sub-
strates (Nagase et al., 2006). This became particularly
evident with the generation of mice models of MMP defi-
ciency. However, unlike most MMP-deletion mice, MMP-14
ablation leads to a severe phenotype, indicating that some
activities of this protease in vivo cannot be replaced by
additional members of this family. Mice deficient for MMP-14
suffered from osteopenia, ankylosis, and progressive fibrosis
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article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).Recently, a model of MMP-14 deficiency has been gener-
ated; similar to the previous model, mice die early because
of cardiac defects, and only a few older mice could also
display some collagen type I accumulation in the skin
(Gutierrez-Fernandez et al., 2015). Thus, despite the fact that
degradation of interstitial collagen fibrils could be catalyzed,
mostly in vitro, by several MMPs (Fields, 2013), MMP-14
(also known as MT1-MMP) seems to be the pivotal collage-
nase in vivo. In skin, collagens I and III are found in the
dermis, with collagen I been the most abundant. At birth,
collagen type III is highly expressed in skin, and over time it
is reduced, leading to a late increased ratio of type I to III
(Gelse et al., 2003). Collagen type I homeostasis in tissues is
finely regulated by a continuous balance of synthesis and
degradation, the alteration of which leads to various pa-
thologies such as scleroderma, keloid, hypertrophic scar
formation, and skin degeneration during aging (Ogawa and
Hsu, 2013). Unexpectedly, most experiments with MMP
knockout mice show protection from bleomycin-induced
fibrosis rather than increased collagen accumulation. The
most convincing evidence for increased fibrosis resulting
from deletion of an MMP comes from studies with MMP-
14edeficient mice (Holmbeck et al., 1999). To further
analyze the functional role of MMP-14 in adulthood we
generated a conditional knockout of MMP-14 in stromal
fibroblasts. To this end, we crossed MMP-14 floxed mice
with Coll a2(I) ER-Cre deleter mice. Upon deletion of
MMP-14 in adult mice fibroblasts, we could detect a marked
skin phenotype with enhanced dermal thickness and tissue
stiffness but no alterations in other organs. This phenotype
was caused by altered balance between collagen type I
synthesis and degradation, with degradation being signifi-
cantly impaired.estigative Dermatology. This is an open access
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Figure 1. Fibroblast-specific
depletion of MMP-14. (a) Genotyping
PCR images used to amplify the LoxP-
flanked exons 2e4 of the MMP-14
gene and the PCR product detected
only upon LoxP recombination. The
lengths (in base pairs) of the amplified
PCR fragments are shown. (b) Mice
after tamoxifen-induced MMP-14
deletion at age 13 weeks (T2). Average
weight of sex- and age-matched mice
is shown (n  7). (c) MMP-14
transcripts amplification in fibroblasts
isolated from adult mouse skin
(5 weeks after tamoxifen).
Immunoblot analysis of MMP-14
expression in isolated primary
fibroblasts. Actin was used as a
control. (d) Real-time PCR
amplifications from skin specimens
collected at T0, T1, and T2. Each dot
represents one specimen/mouse. S26
was used as control. bp, base pairs;
cre, Cre transgene; Ct, cycle
threshold; del, deletion; fl, floxed;
MMP, matrix metalloproteinase;
Sf, stromal fibroblast; T, time.
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Generation of mice with fibroblast-specific depletion of
MMP-14 expression
To explore the functional significance of fibroblast MMP-14
in skin homeostasis, we generated a mouse strain with an
inducible fibroblast-specific depletion of MMP-14, which we
refer to here as MMP-14 stromal fibroblastse/e (MMP-14Sfe/e).
For this purpose, mice carrying the LoxP-flanked exons 2e4
of the MMP-14 gene (MMP-14Sfþ/þ]) were mated with mice
carrying the Cre-ERT fusion transgene under the control of a
minimal collagen-a2 type I promoter and enhancer driving
fibroblast-specific and inducible Cre expression (Sonnylal
et al., 2007; Zheng et al., 2002). At 4 weeks of age, mice
were fed for 4e5 weeks with tamoxifen. We confirmed
in vivo deletion by analysis of genomic DNA, detecting the
floxed allele (fl/fl; MMP-14Sfþ/þ), the presence of the Cre
gene (cre) and a fragment of the MMP-14 gene detectable
upon deletion of exons 2e4 (del; MMP-14Sfe/e) (Figure 1a).
MMP-14 deletion was specifically detected in dermis but not
in epidermis where keratinocytes, melanocytes, Langerhans
cells, and subsets of T cells are present (see Supplementary
Figure S1a online). Upon MMP-14 deletion in fibroblasts,
mice at 13 weeks of age developed smaller than floxed
littermates, with enlarged extremities and tail, but compara-
ble weight (Figure 1b). The skin was tight, thickened, and less
elastic.
In dermal fibroblasts isolated from skin of MMP-14Sfe/e
mice we could not detect MMP-14 transcripts or protein
(Figure 1c). On the contrary, MMP-14 expression was
retained in isolated skin keratinocytes of both mouse geno-
types (see Supplementary Figure S1b). Moreover, real-time
PCR analysis of RNA isolated from MMP-14Sfe/e and MMP-
14Sfþ/þ skin failed to show significant changes in the colla-
genases MMP-8 and -13 and in MMP-15 and -16 (P ¼ 0.2 at
time [T] 1; P ¼ 0.9 at T2) (Figure 1d).Journal of Investigative Dermatology (2016), Volume 136Increased dermal thickness and fibrillar collagen
accumulation in MMP-14Sfe/e mice
In the skin of mice before tamoxifen feeding (T0), skin
morphologies of MMP-14Sfþ/þ and MMP-14Sfe/e mice were
comparable (Figure 2a). After supplying tamoxifen, mice
developed progressive dermal thickening within 1 week after
Cre activation protocol was terminated (T1), with a signifi-
cant increase in skin thickness (P ¼ 0.01) compared with
control littermates (Figure 2a and b). Skin thickening further
progressed after 5 (T2, P ¼ 0.02) and 13 (T4, P ¼ 0.02) weeks
and was still detected at 10 months of age (Figure 2a and b).
A slightly reduced subcutaneous fat layer, but no gross ab-
normalities in the epidermal structures, were detected. His-
tochemical analysis using picrosirius red staining and
polarized light microscopy (Junqueira et al., 1978) showed
increased collagen fibril accumulation and formation of large
bundles in the dermal compartment of MMP-14sfe/e mice
(Figure 2a). Even though MMP-14 deletion was detected by
genotyping of organs, no significant collagen accumulation
was detected in the lungs or in the liver, aorta (see
Supplementary Figure S1c and d), kidneys, and heart until 10
months of age (not shown). In MMP-14 full-knockout mice, a
phenotype resembling early aging has recently been
described (Gutierrez-Fernandez et al., 2015; Holmbeck
et al., 1999; Zhou et al., 2000), but in skin of older mice
(10 months of age), MMP-14Sfe/e expression of p21, a direct
target of p53-induced senescence, was not altered (see
Supplementary Figure S2b online).
A strong increase in the amount of acetic acid/pepsin-
extracted skin collagen was visible by SDS-PAGE (Figure 3a).
In addition, hydroxyproline content analyzed in skin biopsy
samples from four age- and sex-matched MMP-14Sfþ/þ and
MMP-14Sfe/e mice showed a significant increase at both
analyzed time points (T1, P¼ 0.01; T2, P¼ 0.02) (Figure 3b) in
MMP-14Sfe/e compared with MMP-14Sfþ/þ. At these time
Figure 2. Increased dermal thickness over time in MMP-14Sfe/emice. (a) Hematoxylin and eosin and Sirius red staining (analyzed with polarized light) of back
skin from mice at different time points after tamoxifen activation of Cre recombinase. The scheme shows the protocol used for tamoxifen induction and the
analyzed time points post-tamoxifen, which for simplicity were named as T0 ¼ before tamoxifen diet; and T1 ¼ 1 week, T2 ¼ 5 weeks, and T4 ¼ 13 weeks after
feeding protocol was completed; and at the age of 10 months (8 months post-tamoxifen). Scale bar ¼ 100 mm. (b) At each time point, skin sections (6 mm) were
cut and stained with hematoxylin and eosin, and thickness of dermis was measured microscopically and expressed as average thickness  standard deviation
(*P  0.01, n ¼ 4e13). fl, floxed; H&E, hematoxylin and eosin; m, months; MMP, matrix metalloproteinase; Sf, stromal fibroblast; T, time.
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in both mouse genotypes (Figure 3c). Further, real-time anal-
ysis of collagen type III, fibronectin, and a-smooth muscle
actin, associated with skin fibrosis and induced by the profi-
brotic transforming growth factor (TGF)-b (Jinnin, 2010;
Perlish et al., 1988; Varga et al., 1987), also did not show
any significant changes of transcripts at both T1 and T2 (see
Supplementary Figure S2a) and in 10-month-old mice
(see Supplementary Figure S2b). In agreement with these data,
total amounts of TGF-b1 were not altered in skin extracts,
and active TGF-b1 was undetectable (see Supplementary
Figure S2c). To investigate whether accumulation in
collagen type I also results in alterations in the formation of
fibrils, electron microscopy studies were performed on the
dermis of MMP-14Sfe/e andMMP-14Sfþ/þmice. The dermis of
the both animals contained collagen fibrils with a relatively
restricted and comparable distribution of diameter (average
size¼ 81 17 and 79 12 inMMP-14Sfþ/þ andMMP-14Sfe/e
mice) (Figure 3d). Therefore, the fibrotic phenotype in MMP-
14edeficient mice was the result of elevated collagen levelsand not of an increase in fibril diameters. In the skin of MMP-
14Sfe/e mice we also detected large intracellular bundles of
collagen in fibroblast-like cells (Figure 3d, arrowheads).
MMP-14Sfe/e mice display increased tissue stiffness but no
altered collagen cross-linkage, vascular stability, or
inflammation
In systemic sclerosis, the increased deposited collagen shows
hydroxylysine aldehyde-derived collagen cross-links that are
more typical of cartilage and bone (Brinckmann et al., 2001).
To investigate whether the skin phenotype in MMP-14Sfe/e
mice resembles this feature of a sclerotic disease, we
analyzed cross-links in the skin of age- and sex-matched
MMP-14Sfe/e and MMP-14Sfþ/þ mice. We did not detect
any increase in hydroxylysyl pyridinoline and its precursor,
dihydroxylysinonorleucine, which is typical for hard
tissues (Brinckmann et al., 2001). In addition, there were no
changes in the concentration of the Lys aldehyde-derived
cross-link histidinohydroxymerodesmosine. The cross-linked
hydroxylysinonorleucine showed a significant increase atwww.jidonline.org 1577
Figure 3. Accumulation of collagen type I in skin of MMP-14Sfe/e mice. (a) Equal amounts of extracts from the back skin of MMP-14Sfþ/þ and MMP-14Sfe/e
mice were resolved by SDS-PAGE and stained with Coomassie blue. Numbers indicate the different mice; boldface (10, 11, 20, and 21) indicates those from
MMP-14Sfe/e mice. Extracts 3 and 4 are from MMP-14 fl/flCreþ mice before tamoxifen treatment. (b) Collagen content was analyzed in hydrolyzed specimens.
Mean values are shown (*P  0.02, n ¼ 4e5). (c) Collagen type I transcripts in skin specimens; each dot represents one specimen/mouse. S26 was used for
normalization of amplified transcripts. (d) Electron microscopy of skin sections at T2 showing a comparable diameter of fibrils in both mice. The number on the
axis refers to the number of analyzed fibrils. Scale bar ¼ 0.5 mm. Ct, cycle threshold; fl, floxed; MMP, matrix metalloproteinase; Sf, stromal fibroblast; T, time.
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links are not altered, the excessive deposition of collagen and
the increased fibril number may alter the mechanical prop-
erties of the skin in MMP-14Sfe/e mice. Ultimate force, ulti-
mate stress, and Young’s modulus in MMP-14Sfe/emouse skin
were found to be significantly higher than in MMP-14Sfþ/þ
skin (P ¼ 0.01, P ¼ 0.006, and P ¼ 0.01, respectively). In
addition, MMP-14 deletion in skin fibroblasts led to signifi-
cant stiffening (P ¼ 0.01) of the tissue, despite deformability
being comparable in both mouse genotypes (Figure 4b).
Tissue damage, initially involving the endothelium and
inflammation, are critical initiators of skin fibrosis (Denton
et al., 2006). In mice lacking MMP-14 in fibroblasts, we
could not identify any vascular damage, either by immuno-
fluorescence assessment and quantification of blood vessels
(CD31) or by injection of fluorescent dextran used to assess
vascular leakage (see Supplementary Figure S3 online). In
addition, we did not find any significant alteration in lym-
phocytic or myeloid cell infiltration before or at the time of
dermal thickening in the tissues indicative of enhanced
inflammation (data not shown).Journal of Investigative Dermatology (2016), Volume 136Increased accumulation of collagen in MMP-14Sfe/e mouse
skin in vivo and in fibroblasts in vitro
To visualize and analyze the distribution of dermal collagen
we performed classic histochemical stainings based on
Herovici’s protocol, which stains collagen dark pink (mature
[collagen type I]) and blue (young [collagen type III]) in
human and mouse skin (Collins et al., 2011; Fitzgerald et al.,
1996; Watt and Fujiwara, 2011). Whereas the amount of
young collagen (blue) over time was quite comparable in
both mouse genotypes, the amount of mature collagen (dark
pink) was significantly increased in the skin of MMP-14Sfe/e
compared with control mice (Figure 5). To directly address
whether increased collagen results from impaired degrada-
tion, we isolated fibroblasts from these mice and analyzed
them in culture. MMP-14Sfe/e fibroblasts accumulated
collagen type I protein in both supernatants and cell layer.
Increased collagen type I was also visible by immunostaining
of monolayer cultures (Figure 6a). De novo synthesis of
collagen type I, as detected by real-time PCR, was not
significantly altered, although transcripts were slightly
increased (Figure 6b).
Figure 4. Altered mechanical properties, but not cross-link types, in skin from MMP-14Sfe/emice. (a) Analysis of collagen cross-link formation in skin samples;
depicted is the average ratio of HP þ DHLNL to HLNL crosslinks (n  4). (b) Different mechanical properties were determined in back skin specimens freshly
prepared from MMP-14Sfþ/þ and MMP-14Sfe/e mice at T2 (*P  0.01,**P  0.001). Each dot represents one specimen/mouse; black dots ¼ males, grey
dots ¼ females (n  9). HHMD, Lys aldehyde-derived cross-link histidinohydroxymerodesmosine; HLNL, hydroxylysinonorleucine; DHLNL,
dihydroxylysinonorleucine; HP, hydroxylysyl pyridinoline; MMP, matrix metalloproteinase; n.s., not significant; Sf, stromal fibroblast.
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involved in downstream processing of collagen type I and
whose activation is induced by culturing fibroblasts in three-
dimensional collagen lattices (Fields, 2013; Zigrino et al.,
2001). When cultured in collagen lattices, fibroblasts from
MMP-14Sfe/e mice did not lose their capacity to contract
the gel (see Supplementary Figure S4a online) but almost
completely lost the ability to activate proMMP-2, whereas
this was retained in MMP-14Sfþ/þ fibroblasts (Figure 6d, and
see quantification in Supplementary Figure S4b). Using an
in vitro degradation assay (Ruangpanit et al., 2002), we could
detect collagen degradation areas (in white) by fibroblasts
from MMP-14Sfþ/þ cultured on a layer of fibrillar collagen.
This was further enhanced by the presence of two inducers
of MMP expression/activity, tumor necrosis factor and IL-1,
and abolished by the MMP inhibitor GM6001 (Figure 6c).
However, in normal culture conditions or in the presence
of the inducers we could not detect any degradation of
fibrillar collagen by MMP-14Sfe/e fibroblasts (Figure 6c and
see quantification in Supplementary Figure S4c).Comparable collagen synthesis in bleomycin-induced
fibrosis and in wound repair
A murine model of skin fibrosis induced by subcutaneous
injection of bleomycin has been described (Yamamoto et al.,
1999). Based on this model system, skin lesions generated in
MMP-14Sfe/e and MMP-14Sfþ/þ mice showed dense accu-
mulation of collagen in the dermis and replacement of
subcutaneous fat by connective tissue (see Supplementary
Figure S5 online). In both mouse genotypes, the dermal
thickness of bleomycin lesions was increased to the same
twofold extent over control saline-injected sites, indicating
that collagen production is comparable in MMP-14Sfe/e and
MMP-14Sfþ/þ mice. By Herovici’s staining we detected a
significant increase in collagen type I and III upon bleomycin
stimulation of both mouse genotypes (see Supplementary
Figure S5). Interestingly, when mice were left to recover for
4 weeks after bleomycin treatment, skin thickness and
amount of collagen type I were significantly reduced in
MMP-14Sfþ/þ but not in MMP-14Sfe/e mice (see





























Figure 5. Mature collagen is significantly accumulated in skin of MMP-
14Sfe/e mice. Herovici’s staining of skin at the two indicated time points was
analyzed by light microscopy. Colors on images were inverted and split into
single channels to separately assess the amount of blue (young, collagen type
III) or pink (mature, collagen type I) collagen fibrils. Quantification of the
average of both colors is shown on the right (n ¼ 10 at T1 and T2; n ¼ 6
at 10 months, each for MMP-14Sfþ/þ and MMP-14Sfe/e). ***P < 0.001. MMP,
matrix metalloproteinase; Sf, stromal fibroblast; T, time.
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1580A temporarily and locally restricted fibrotic reaction is also
observed during tissue repair. To investigate the physiological
role of fibroblast MMP-14 in wound-healing responses, we
generated excisional skin wounds on the backs of 8-week-old
MMP-14Sfe/e and MMP-14Sfþ/þ littermates. Wound closure
was followed over time and expressed as a percentage of the
initial wound area. The kinetics of wound repair were com-
parable in both mice (see Supplementary Figure S7a online).
Histological examination of wounds at day 11 postwounding
indicated a comparable formation of granulation tissue in
quantity (see Supplementary Figure S7b) and collagen
deposition (Sirius red stain). Collagen type I and III were
present in the granulation tissue at day 13 with prevalence of
the collagen III (see Supplementary Figure S7c). In addition,
invasion of vascular structures, as shown by CD31 staining,
was comparable in both mouse systems (see Supplementary
Figure S7c).DISCUSSION
Metalloproteinases have been implicated in direct or indirect
remodeling of the ECM. In vivo analysis of MMP deficiency
has shown that the activity of most MMPs can be efficiently
compensated (Page-McCaw et al., 2007). However, in case of
MMP-14, constitutive deletion leads to early postnatal death
within 3 weeks (Gutierrez-Fernandez et al., 2015; Holmbeck
et al., 1999; Zhou et al., 2000). Only a few mice that reached
older age also presented with a local accumulation of
collagen in the skin (Holmbeck et al., 1999). Using mice with
conditional knockout of MMP-14 in stromal fibroblasts, we
showed that ablation of MMP-14 in fibroblastic cells in adultJournal of Investigative Dermatology (2016), Volume 136skin results in a fibrotic skin phenotype. This effect was
limited to the skin and was not detected in the kidney, liver,
and lungs, although collagen a2 (I) Cre promoter was shown
to be active in fibroblasts in the lungs and kidney (Zheng
et al., 2002). A possible explanation is that activity of
MMP-14 in collagen turnover in these organs is not relevant
or is efficiently replaced by other collagenases. In lung, for
instance, during embryonal development expression of
MMP-14 and -2 is high, but both taper off with the comple-
tion of lung development (Greenlee et al., 2007). Additional
collagenases may exert a major role in lung homeostasis,
possibly MMP-8 and MMP-13, which are also found to be
induced in chronic obstructive pulmonary disease (Woode
et al., 2015), or MMP-1, which is absent in fibroblast foci
from idiopathic pulmonary fibrosis (Pardo and Selman,
2012). In skin, MMP-8 and MMP-13 collagenolytic activity
may be of secondary importance to MMP-14, because mice
deleted for the single enzymes failed to show any constitutive
skin phenotype even in adulthood (Page-McCaw et al.,
2007).
Collagen type I turnover in vivo in skin is reported to be
quite long, with an estimated half-life of approximately 15
years in human and 74e80 days in rat and mouse skin
(Ohuchi and Tsurufuji, 1970; Rucklidge et al., 1992; Verzijl
et al., 2000). Collagen accumulation in skin of MMP-14Sfe/e
mice was detected up to 10 months of age and was not
accompanied by significant alterations in de novo synthesis,
indicating that impaired degradation may alter collagen
homeostasis and thus collagen half-life. Electromicroscopy
analysis of MMP-14Sfe/e mouse skin at different stages of
progressive fibrosis did not detect alterations in fibrils or
collagen bundle form and size compared with controls. A
large accumulation of collagen type I is typically detected in
fibrotic tissue, where normal architecture is replaced with a
largely acellular, collagen-rich, stiff connective tissue
(Bhattacharyya et al., 2012). In agreement, the skin of MMP-
14Sfe/e mice had increased tissue tensile strength, stress, and
stiffness and Young’s modulus compared with control ani-
mals. Even though an increased ratio of posttranslational
collagen modifications have also been implicated in altering
mechanical properties of the skin, we could not detect
any major alteration in the amounts or pattern of collagen
cross-links typically observed in human sclerosis and
bleomycin-induced skin fibrosis in mice (Brinckmann et al.,
2001; Willenborg et al., 2014; Yamamoto et al., 1999).
Mouse models of sclerotic skin diseases comprise
inflammation-dependent (bleomycinmodel) and inflammation-
independent types. The latter can be subdivided into
models with higher TGF-b levels or a lack of collagen
degradation (Denton and Abraham, 2004; Yamamoto et al.,
1999). Further, fibrosing skin diseases, such as human
scleroderma, are thought to stem from vascular defects and
enhanced inflammatory reactions (Denton et al., 2006). In
MMP-14Sfe/e mouse skin at stages before and after signifi-
cant dermal thickening, we did not detect obvious abnor-
malities in blood vessels and in the amount of inflammatory
cells infiltrating the tissue. These data, together with the
lack of cross-link alterations, indicate that lack of MMP-14
in adult skin induces a type of fibrosis due to reduced
degradation but not to inflammation.
Figure 6. MMP-14 is the main collagenolytic enzyme in adult skin fibroblasts. (a) Fibroblasts from two different mice per genotype (Sfþ/þ, mice 3 and 7) and
(Sfe/e, mice 5 and 6) were cultured as monolayers for 4 days. Collagen type I was detected in immunoblots (10 mg) and by immunofluorescence (right). Actin
was used as control. Scale bar ¼ 100 mm. (b) Collagen type I transcripts in independent cultures of fibroblasts. (c) Collagenolytic activity of fibroblasts seeded on
a reconstituted type I collagen film in the absence (-) or presence (þ) of tumor necrosis factor, IL-1, or GM6001 inhibitor. Collagen degradation is detected as
white areas on a blue background (arrowheads). The experiment was repeated twice in triplicate. (d) Gelatin zymography of supernatants (normalized to the cell
lysates) from Sfþ/þ and Sfe/e cultured as indicated. Ct, cycle threshold; M, marker; MMP, matrix metalloproteinase; ns, not significant; PDGFR, platelet-derived
growth factor receptor; Sf, stromal fibroblast; T, time; TNF, tumor necrosis factor.
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result in decreased levels of total TGF-b1 signaling and
enhanced vascular leakiness (Sounni et al., 2010). On the
contrary, in a recently generated model of MMP-14 defi-
ciency, a significant increase in TGF-b1 expression levels was
detected (Gutierrez-Fernandez et al., 2015). In the fibroblast-
specific MMP-14 knockout model, we could not find
alterations in TGF-b1 levels in skin; in agreement, vessel
permeability to dextran was comparable to that of wild types,
and collagen synthesis also was not altered. This would imply
that, unlike fibroblast MMP-14edeletion mice, the effect
detected in constitutive MMP-14 knockout mice may result
from alterations in cell types other than fibroblasts in tissue.
Additional possible explanations are that, in the absence
of MMP-14, processing of additional factors or receptors is
altered. These may in turn contribute to counteract alterations
in TGF-b signaling. Endoglin, for example, is a trans-
membrane protein acting as a TGF-b auxiliary receptor.
Either as full length or in soluble form (spliced or the MMP-
14eshed form), endoglin may affect differential TGF-b1
signaling or CCN2 (alternative name, connective tissue
growth factor, or CTGF) synthesis and thus positively or
negatively affect subsequent signaling (Maring et al., 2012).
Surprisingly, despite the increased skin stiffness we detected
in MMP-14Sfe/e mice, the number of a-smooth muscle
actinepositive myofibroblasts, whose differentiation can be
driven by the mechanical properties of the surrounding ma-
trix (Hinz, 2009), was not altered. However, this correlatedwith unaltered levels of TGF-b1 and possibly indicates that
matrix modifications such as collagen cross-links, which
were not altered in our system, are necessary, together with
increased collagen, for the induction of myofibroblast
differentiation.
However, our data indicate that lack of MMP-14 represents
a pathogenic mechanism of fibrotic disease, which is inde-
pendent of TGF-b, inflammation, and vascular damage. This
was supported by the observation that in two models of
fibrosis in mice, namely bleomycin induced and wound
healing (scar formation), we could not observe any major
alterations compared with control mice. In agreement with
previous studies showing restoration of dermal thickness after
bleomycin treatment as result of proteolysis (van der Slot-
Verhoeven et al., 2005), dermal thickening was diminished
after a resting period in wild-type mice but not in MMP-14Sfe/e
mice. This would corroborate the major role for MMP-14 in
collagen degradation in skin.
Lack of alterations in granulation tissue formation during
tissue repair may suggest that this process is independent of
fibroblast-derived MMP-14. At this late stage, macrophages
in granulation tissue may clear excess ECM in the scar
(Rohani et al., 2015; Rohani and Parks, 2015). Because we
did not detect alterations in scar formation in the macrophage
MMP-14 mouse mutants (Klose et al., 2013), it is conceivable
that collagenolytic activity in scar derives from another
enzyme, possibly MMP-13, that is pivotal in this process in
liver fibrosis (Fallowfield et al., 2007).www.jidonline.org 1581
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accumulation of collagen type I was also detected in MMP-
14Sfe/e fibroblasts in culture with no significant enhancement
of collagen de novo synthesis, pointing once more to a
degradative but not synthetic phenotype. In vitro, MMP-
14Sfe/e fibroblasts lost their ability to process fibrillar
collagen type I and to activate proMMP-2. These observations
were made also for MMP-14 knockout mice, in which no
alteration in skin in vivo was detected. This was likely
because of the early postnatal death of the mice (Holmbeck
et al., 1999). Our analysis shows that in adult skin, MMP-
14 is the collagenolytic enzyme responsible for collagen
remodeling. MMP-14 has a pivotal role in adult collagen
homeostasis, and inhibition of its expression and activity may
contribute to pathogenesis of fibrosis.
MATERIALS AND METHODS
Generation of fibroblast-specific MMP-14eknockout mice
The mouse strain with floxed MMP-14 has been described previ-
ously (Zigrino et al., 2012). Mice were crossed to a mouse line that
expresses the estrogen receptor inducible Cre recombinase under
the control of a fibroblast-specific regulatory fragment of the pro-a2
(I) collagen gene (Sonnylal et al., 2007; Zheng et al., 2002). Cre
activity was induced in all animals including controls starting from 4
weeks of age by feeding with tamoxifen (400 mg/mg pellets;
Haarlan, Venray, The Netherlands) for 4e5 weeks. Animals were
housed under specific pathogen-free conditions in a 12-/12-hour
light/dark cycle with free access to food and fresh water ad libi-
tum. Mice were killed by carbon dioxide. For experimental skin
fibrosis we used an established mouse protocol (Yamamoto et al.,
1999); further information is provided in the Supplementary
Materials online. All animal experiments were performed in
compliance with German Regulations for Welfare of Laboratory
Animals and were approved by the Regierungspra¨sidium Ko¨ln,
Germany (NRW authorization 50.203.2-K 37a, 20/05 and
AZ2010.A342).
All additional experimental procedures are described in detail in
the Supplementary Materials and Methods.
Tensile strength measurements
Full-thickness (hourglass-shaped form, width ¼ 5 mm in middle and
10 mm at the ends, length ¼ 25 mm) stripes of skin from 13-week-
old tamoxifen-induced mice (T2) were used to determine the tensile
strength by a material testing machine (Z2.5/TN1S; Zwick GmbH &
CoKG, Ulm, Germany) with a load cell of 100 N (Lettmann et al.,
2014). Samples were fixed between two rippled clamps. After pre-
loading (0.05 N, 0.1 mm/s), skin was stretched with a crosshead
speed of 15 mm/min until failure. To calculate the stress, skin
thickness was assessed in sections prepared for histological analysis.
Stiffness and Young’s modulus were determined from the slope of the
linear portion of the load-deformation and stress-strain curves,
respectively. Detailed information on the parameters used is
provided in the Supplementary Materials.
Processing of tissues
The acetic acid extraction of collagen was performed as previously
described (Asano and Trojanowska, 2013). Skin punches (6 mm)
were taken from the back of each mouse (sex and age matched),
minced, and incubated in phosphate-buffered saline overnight at
4C with stirring. Tissue was harvested by centrifugation at 12,000g
for 15 minutes and suspended in 10 volumes of cold 0.5 mol/LJournal of Investigative Dermatology (2016), Volume 136acetic acid with the addition of pepsin (1:10 ratio of pepsin to tissue
wet weight). Extraction was performed overnight at 4C with stirring,
and supernatant was dialyzed against 0.1 mol/L acetic acid. Speci-
mens were stored at e20C before processing.
Cell collagen degradation assay
The capacity of cells to degrade type I collagen fibrils was assessed
as described (Holmbeck et al., 1999). Twenty-four multiwell plates
were coated with a film of reconstituted rat tail tendon type I
collagen fibrils, and fibroblasts from MMP-14Sfe/e and control mice
were cultured on top of this layer for 5 hours. After washing 3 times
in phosphate buffered saline, cells were incubated for 5 days in
serum free Opti-MEM I (GIBCO-BRL, Gaithersburg, MD) with or
without addition of 109 mol/L of IL-1b, 108 mol/L of tumor
necrosis factor-a, and 20 mmol/L of GM6001. After incubation, cells
were removed with trypsin/EDTA, and the residual collagen fibril
film was stained with Coomassie blue (Sigma). Experiments were
repeated twice, each using two independently isolated MMP-14Sfþ/þ
and MMP-14Sfe/e fibroblasts (four independent fibroblast lines).
Statistics
Statistical analysis was performed using GraphPad Prism (GraphPad,
San Diego, CA). Two-tailed Student t test was used for data analysis,
with P < 0.05 considered to be statistically significant. For multiple
comparisons we used analysis of variance tests.
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